China's Fosun Pharma raises offer for hospital chain Chindex Int'l to $223.6 mln
April 21, 2014 at 05:18 AM EDT
SHANGHAI, April 21 (Reuters) - Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed Chindex International Inc by 15 percent to $223.6 million after a bidding war for the China-focused hospital chain.
